Chinese research team launches clinical trial for invasive bracein-computer interface
Xinhua
13th June 2025
Chinese research team launches clinical trial for invasive bracein-computer interface
This is not a science-fiction premise, but China's first-in-human clinical trial of an invasive BCI, and an important step in the transition of this technology from laboratory research to clinical application.
The trial is a collaboration between research teams from the Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) at the Chinese Academy of Sciences (CAS), and Huashan Hospital affiliated with Fudan University. Their work makes China the second country, after the United States, to advance invasive BCI technology to the clinical trial stage.
Since the device was implanted in March 2025, it has operated stably in the patient's brain, with no infection or electrode failure reported to date, according to the research team.
Comments